Literature DB >> 26748453

Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.

Kim-Ann Saal1, Dagmar Galter2, Sigrun Roeber3, Mathias Bähr1,4, Lars Tönges1,4, Paul Lingor1,4.   

Abstract

Causative treatment strategies for Parkinson's disease (PD) will have to address multiple underlying pathomechanisms to attenuate neurodegeneration. Additionally, the intrinsic regenerative capacity of the central nervous system is also an important factor contributing to restoration. Extracellular cues can limit sprouting and regrowth of adult neurons, but even aged neurons have a low intrinsic regeneration capacity. Whether this capacity has been lost or if growth inhibitory cues are increased during PD progression has not been resolved yet. In this study, we assessed the regenerative potential in the nigrostriatal system in post-mortem brain sections of PD patients compared to age-matched and young controls. Investigation of the expression pattern of the regeneration-associated protein GAP-43 suggested a lower regenerative capacity in nigral dopaminergic neurons of PD patients. Furthermore, the increase in protein expression of the growth-inhibitory protein ROCK2 in astrocytes and a similar trend in microglia, suggests an important role for ROCK2 in glial PD pathology, which is initiated already in normal aging. Considering the role of astro- and microglia in PD pathogenesis as well as beneficial effects of ROCK inhibition on neuronal survival and regeneration in neurodegenerative disease models, our data strengthens the importance of the ROCK pathway as a therapeutic target in PD.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  GAP-43; Parkinson's disease; ROCK; astrogliosis; microgliosis; regeneration; rho kinase; striatum; substantia nigra

Mesh:

Substances:

Year:  2016        PMID: 26748453     DOI: 10.1111/bpa.12346

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  13 in total

Review 1.  Biomarkers of Parkinson's disease: 20 years later.

Authors:  Rezzak Yilmaz; Franziska Hopfner; Thilo van Eimeren; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2019-04-04       Impact factor: 3.575

2.  Serum Level of Growth-Associated Protein 43 Is Associated with First-Episode Schizophrenia Patients without Antipsychotic Drugs Treatment.

Authors:  Libin Xiao; Xiaowei Tang; Xiuxiu Hu; Xiaotang Feng; Ronglan Gong; Fujun Wang; Xiangrong Zhang
Journal:  Comput Intell Neurosci       Date:  2022-05-16

3.  Genetic association of the human GAP43 gene with schizophrenia in a Northeast Chinese Han population.

Authors:  Zhilin Luan; Wenhua Ming; Xiaoxiao Huo; Jingwei Yu; Bing Wang; Yang Sun
Journal:  Indian J Psychiatry       Date:  2020-07-27       Impact factor: 1.759

4.  Reg-2, A Downstream Signaling Protein in the Ciliary Neurotrophic Factor Survival Pathway, Alleviates Experimental Autoimmune Encephalomyelitis.

Authors:  Hong Jiang; Ke-Wei Tian; Fan Zhang; Beibei Wang; Shu Han
Journal:  Front Neuroanat       Date:  2016-05-09       Impact factor: 3.856

Review 5.  Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson's Disease and Amyotrophic Lateral Sclerosis.

Authors:  Anna-Elisa Roser; Lars Tönges; Paul Lingor
Journal:  Front Aging Neurosci       Date:  2017-04-04       Impact factor: 5.750

6.  The protective effect of non-invasive low intensity pulsed electric field and fucoidan in preventing oxidative stress-induced motor neuron death via ROCK/Akt pathway.

Authors:  Chih-Hsiung Hsieh; Chueh-Hsuan Lu; Yu-Yi Kuo; Guan-Bo Lin; Chih-Yu Chao
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

7.  Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes.

Authors:  Hannah Scheiblich; Cira Dansokho; Dilek Mercan; Susanne V Schmidt; Luc Bousset; Lena Wischhof; Frederik Eikens; Alexandru Odainic; Jasper Spitzer; Angelika Griep; Stephanie Schwartz; Daniele Bano; Eicke Latz; Ronald Melki; Michael T Heneka
Journal:  Cell       Date:  2021-09-22       Impact factor: 41.582

8.  Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.

Authors:  Be'eri Niego; Natasha Lee; Pia Larsson; T Michael De Silva; Amanda E-Ling Au; Fiona McCutcheon; Robert L Medcalf
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

9.  Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice.

Authors:  Shuang-Feng Xu; Yan-Hui Zhang; Shan Wang; Zhong-Qiu Pang; Yong-Gang Fan; Jia-Yi Li; Zhan-You Wang; Chuang Guo
Journal:  Redox Biol       Date:  2018-12-21       Impact factor: 11.799

Review 10.  Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Authors:  Maria Angela Samis Zella; Judith Metzdorf; Friederike Ostendorf; Fabian Maass; Siegfried Muhlack; Ralf Gold; Aiden Haghikia; Lars Tönges
Journal:  Cells       Date:  2019-01-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.